Clinical Trials Directory

Trials / Completed

CompletedNCT02713022

Body Composition and White Adipose Tissue Inflammation

Status
Completed
Phase
Study type
Observational
Enrollment
202 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators want to find a better way to predict the risk of having fatty tissue inflammation by using a different approach to finding out body fat composition. In this study, the investigators want to estimate the body fat composition using a DEXA scan. DEXA stands for dual energy X-ray absorptiometry. It is the standard and established test to determine bone mineral density (how strong the bones are) to diagnose osteoporosis. This test can also be used to determine the body composition including percent body fat and lean mass. The investigators will compare the participants DEXA scan results for body fat composition to the inflammation found in the breast tissue from the mastectomy to see if there is a relationship. If successful, this may help us predict which patients may be at risk for breast cancer in the future. In addition, the investigators will compare the participants DEXA scan results for body fat composition and inflammation found in the fat tissue from the mastectomy or prostatectomy to the level of exercise activity as measured by a short questionnaire to see if there is a relationship. The investigators will also measure the participants waist to hip ratio. Finally, at the time the participant has blood drawn for their standard presurgical testing, the investigators will also test the blood for prediabetes using a blood test called hemoglocin A1c. The investigators will also measure for the participants waist to hip ratio, and a Hgb A1c blood drawn will be take at the time of presurgical testing. If not feasible, Hgb A1c can be drawn at a separate visit prior to the DEXA scan. If successful, this may help us predict which patients may be at risk for breast cancer in the future.

Conditions

Interventions

TypeNameDescription
DEVICEDEXA Scan
BEHAVIORALGodin Leisure Time Exercise Questionnaire (GLTEQ)

Timeline

Start date
2015-11-04
Primary completion
2023-11-07
Completion
2023-11-07
First posted
2016-03-18
Last updated
2023-11-08

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02713022. Inclusion in this directory is not an endorsement.